Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Sawyers Charles Lazelle Director Grant or award +18,980 18,984
2026-06-11 Rosenberg Aaron Chief Financial Officer Grant or award +71,175 397,891
2026-06-11 Rosenberg Aaron Chief Financial Officer Sale −631 $257.74 $163K 0
2026-06-11 Rosenberg Aaron Chief Financial Officer Grant or award · Share Option (Right to Buy) +137,865 137,865
2026-06-11 Lee Chan Henry SVP, General Counsel Grant or award +45,071 346,554
2026-06-11 Lee Chan Henry SVP, General Counsel Sale −428 $257.64 $110K 0
2026-06-11 Lee Chan Henry SVP, General Counsel Grant or award · Share Option (Right to Buy) +87,308 87,308
2026-06-11 Dugan Margaret Director Grant or award +18,980 73,164
2026-06-11 Riva Alessandro Director Grant or award +18,980 73,164
2026-06-11 Wang Lai President, Global Head of R&D Grant or award +118,625 1,710,085
2026-06-11 Wang Lai President, Global Head of R&D Sale −756 $261.00 $197K 0
2026-06-11 Wang Lai President, Global Head of R&D Grant or award · Share Option (Right to Buy) +229,775 229,775
2026-06-11 Wu Xiaobin President and COO Grant or award +118,625 1,308,161
2026-06-11 Wu Xiaobin President and COO Sale −626 $261.20 $164K 0
2026-06-11 Wu Xiaobin President and COO Grant or award · Share Option (Right to Buy) +229,775 229,775
2026-06-11 Ball Titus B. Principal Accounting Officer Grant or award +31,213 99,645
2026-06-11 Ball Titus B. Principal Accounting Officer Sale −49 $256.39 $13K 120
2026-06-11 Ball Titus B. Principal Accounting Officer Sale −120 $257.53 $31K 0
2026-06-11 Wang Xiaodong Director Grant or award +99,892 4,682,493
2026-06-11 Wang Xiaodong Director Grant or award · Share Option (Right to Buy) +193,492 193,492

Page 11 of 71 · 1,406 trades